US 9,428,494 B2 · Therapeutic compounds

Abstract

The invention provides novel compounds of formula I: that are opioid receptor ligands. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to a mammal in need of treatment. Compounds of the invention are useful to modulate (e.g. agonize or antagonize) opioid receptor function.

Claims2

Dependent claims

A compound which is a compound of formula 1 or 2:

or a salt thereof.

Dependencies are inferred from the claim text.

Facts

Application

12/513,093Filed 2 Nov 2007 · us provisional application

Priority

2 Nov 2006

Published

US 2010/0179217 A115 Jul 2010

Granted

30 Aug 2016

Term ends

Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07D 407/04
Containing two hetero rings: directly linked by a ring-member-to-ring-member bond
A61P 25/32
For treating abuse or dependence: alcohol-abuse
A61P 25/36
For treating abuse or dependence: opioid-abuse
C07D
Heterocyclic compounds

Abstract

Claims2

Dependent claims

A compound which is a compound of formula 1 or 2:

or a salt thereof.

Dependencies are inferred from the claim text.

Therapeutic compounds

Life of this patent

Abstract

Claims2

Therapeutic compounds

Life of this patent

Abstract

Claims2